Reliance Industries Ltd.

Reliance Industries’ subsidiary-- Reliance Life Sciences has developed an RT-PCR kit that promises diagnosis of COVID-19 infection in about 2 hours. Computational biologists at Reliance Life Sciences analyzed more than 100 genomes of SARS-CoV-2 sequenced in India and designed unique RT-PCR primers for developing quantitative-Real Time PCR (RT-PCR) kit for COVID-19 detection. RT-PCR kit is so far considered as Gold standard.

The kit is named R-Green Kit (SARS COV2-real-time PCR) and has been technically validated by ICMR for satisfactory performance. ICMR's validation process does not approve/disapprove the kit design as well as it does not certify user-friendliness. The kit can detect the presence of E-gene, R-gene, RdRp gene of SARS COV2 virus with Actin as an internal control. As per ICMR results, the kit shows 98.7 percent sensitivity and 98.8 percent specificity.

Reliance Industries is India’s largest private sector company. The company’s activities span hydrocarbon exploration and production, petroleum refining and marketing, petrochemicals, retail and 4G digital services.